​

Corcept Therapeutics Ownership | Who Owns Corcept Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Corcept Therapeutics Ownership Summary

Corcept Therapeutics is owned by 21.57% institutional investors, 11.54% insiders, and 66.89% retail investors. Blackrock is the largest institutional shareholder, holding 16.09% of CORT shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.29% of its assets in Corcept Therapeutics shares.

CORT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCorcept Therapeutics21.57%11.54%66.89%
SectorHealthcare Stocks 35.70%12.04%52.26%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock16.54M16.09%$537.36M
Blackrock funding, inc. /de12.15M11.70%$489.82M
Vanguard group9.49M9.17%$330.42M
Ingalls & snyder7.61M7.33%$306.71M
Renaissance5.68M5.47%$229.07M
Parallel advisors3.98M3.83%$160.33M
State street3.20M3.08%$129.03M
Fmr3.19M3.07%$128.60M
Geode capital management2.71M2.61%$109.40M
First trust advisors lp2.17M2.09%$87.61M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tanaka capital management111.21K16.64%$9.24M
Checkpoint capital392.33K10.92%$32.61M
Ingalls & snyder7.61M10.86%$306.71M
Sio capital management674.76K3.90%$27.20M
Propel bio management147.83K3.80%$6.02M
Tang capital management1.50M3.07%$60.47M
Bioimpact capital985.70K3.07%$39.73M
Parallel advisors3.98M2.88%$160.33M
Fas wealth partners308.32K1.74%$25.62M
Boxer capital management250.00K1.32%$10.08M

Top Buyers

HolderShares% AssetsChange
First trust advisors lp2.17M0.06%1.48M
Tang capital management1.50M3.07%1.34M
D. e. shaw1.18M0.03%1.01M
Bioimpact capital985.70K3.07%985.70K
Ubs group1.36M0.01%948.82K

Top Sellers

HolderShares% AssetsChange
Novo---2.41M
Td asset management---994.84K
Ikarian capital---994.50K
Epoch investment partners---816.65K
Jpmorgan chase200.95K0.00%-633.50K

New Positions

HolderShares% AssetsChangeValue
Bioimpact capital985.70K3.07%985.70K$39.73M
Norges bank695.77K0.00%695.77K$24.21M
Sio capital management674.76K3.90%674.76K$27.20M
Vanguard fiduciary trust590.31K0.01%590.31K$23.80M
Soleus capital management285.53K0.47%285.53K$11.51M

Sold Out

HolderChange
Tortoise investment management-1.00
Tfc financial management-1.00
Horizon investments-3.00
Turning point benefit group-3.00
Hfm investment advisors-4.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026178-57.31%22,402,023-70.75%210.39%71-61.41%72-54.43%
Dec 31, 2025281-37.56%56,456,655-26.85%540.99%115-47.25%111-24.49%
Sep 30, 2025427-0.93%76,942,4182.16%731.41%209-5.86%137-9.87%
Jun 30, 2025432-3.79%78,890,554-3.87%751.22%221-7.14%15410.79%
Mar 31, 202544914.83%82,236,144-2.40%781.19%23615.12%14015.70%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF5.68M5.29%1.98K
Vanguard Total Stock Mkt Idx Inv2.88M2.68%24.55K
Vanguard US Total Market Shares ETF2.83M2.68%213.93K
Vanguard Small Cap Index2.08M1.94%-4.85K
iShares Russell 2000 ETF2.03M1.91%-
First Trust NYSE Arca Biotech ETF1.84M1.72%-7.98K
Fidelity Contrafund1.19M1.10%-
Vanguard Small Cap Growth Index Inv1.17M1.09%-668.00
Vanguard Institutional Extnd Mkt Idx Tr1.06M0.98%9.86K
State Street SPDR Port S&P 600 Sm CpETF860.08K0.80%-

Recent Insider Transactions

DateNameRoleActivityValue
Jul 07, 2026Guyer William Chief Development OfficerSell$89.05K
Jul 07, 2026Guyer William Chief Development OfficerSell$1.77M
Jul 01, 2026Maduck Sean See RemarksSell$962.78K
Jul 01, 2026Maduck Sean See RemarksSell$998.03K
Jul 01, 2026Maduck Sean See RemarksSell$247.92K

Insider Transactions Trends

DateBuySell
2026 Q3-5
2026 Q2-18
2026 Q125
2025 Q4-26
2025 Q3-31

CORT Ownership FAQ

Who owns the most shares of Corcept Therapeutics?

Corcept Therapeutics’s largest shareholders are Blackrock (16.54M shares, 16.09%), Blackrock funding, inc. /de (12.15M shares, 11.70%), and Vanguard group (9.49M shares, 9.17%). Together, they hold 36.96% of Corcept Therapeutics’s total shares outstanding.

Does Blackrock own Corcept Therapeutics?

Yes, BlackRock owns 16.09% of Corcept Therapeutics, totaling 16.54M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 537.36M$. In the last quarter, BlackRock decreased its holdings by -287K shares, a -1.71% change.

Who is Corcept Therapeutics’s biggest shareholder by percentage of total assets invested?

Tanaka capital management is Corcept Therapeutics’s biggest shareholder by percentage of total assets invested, with 16.64% of its assets in 111.21K Corcept Therapeutics shares, valued at 9.24M$.

Who is the top mutual fund holder of Corcept Therapeutics shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Corcept Therapeutics shares, with 5.29% of its total shares outstanding invested in 5.68M Corcept Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools